Professor Lionel Tarassenko, President of Reuben College, has been awarded the BioMedEng Legacy Prize at an awards ceremony at the national conference of UK biomedical engineers, BioMedEng22, in London on Thursday 8th September 2022.
The BioMedEng Legacy Award is awarded to a UK Biomedical Engineer whose career-long research and mentoring have made an immense contribution to inspiring and training the next generation of academics, researchers and students in the discipline.
Professor Tarassenko’s work has had a major impact on the identification of deterioration in acute care and on the management of chronic disease. Having first studied at Oxford in the late 1970s, he was elected to the Chair of Electrical Engineering and to a Professorial Fellowship at St John’s College in 1997. He was the driving force behind the creation of the Institute of Biomedical Engineering (IBME) which he directed from its opening in April 2008 to October 2012. The system which he designed for patient monitoring in critical care was the first machine learning system to gain FDA approval (in 2008).
Professor Tarassenko is the author of 250 journal papers, 220 conference papers, 3 books and 32 granted patents. He is a director of the University’s wholly-owned technology transfer company, Oxford University Innovation, and has founded four University spin-out companies. He was the Head of the Department of Engineering Science (Dean of Engineering) from 2014 to 2019, and is now the Founding President of Reuben College.
Lionel said: “In the time since I completed my PhD in the Department of Paediatrics in Oxford in 1985, biomedical engineering in the UK has grown from a minority interest to a major subject, both at the undergraduate and postgraduate levels. I am delighted to have played a role in the growth of the subject, in partnership with others in Oxford and beyond, and honoured to receive an award from my peers which recognizes this.”
Professor Tarassenko being awarded the Biomedical Engineering Legacy Award